Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Genomic Profiling”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02437617
What this trial is testing

Genomic Profiling Assay in Phase I

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 500
Not applicableUnknownNCT00903565
What this trial is testing

A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint

Who this might be right for
Colon Cancer
Agendia 1,200
Not applicableLooking for participantsNCT06781151
What this trial is testing

Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB

Who this might be right for
Ovarian Cancer RecurrentEndometrial Cancer RecurrentCervical Cancer Recurrent
Sun Yat-sen University 200
Not applicableLooking for participantsNCT05234177
What this trial is testing

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Who this might be right for
Colorectal Cancer
Tempus AI 300
Not applicableStudy completedNCT03183050
What this trial is testing

MEND 2: Making Treatment Decisions Using Genomic Testing

Who this might be right for
Breast Cancer Female
Georgetown University 88
Not applicableLooking for participantsNCT07649629
What this trial is testing

Impact of Liquid Biopsy on the Therapeutic Pathway for Lung Cancer: Advancing the Molecular Characterization of Patients With Advanced Lung Adenocarcinoma by Integrating Liquid Biopsy Into the Early Stages of the Diagnostic and Therapeutic Pathway

Who this might be right for
Advanced Non-small Cell Lung Cancer (NSCLC)
Regina Elena Cancer Institute 70
Not applicableEnded earlyNCT02454595
What this trial is testing

Registry to Measure the Impact of Adding Genomic Testing

Who this might be right for
Prostate Cancer
Myriad Genetic Laboratories, Inc. 116
Not applicableNot Yet RecruitingNCT06195904
What this trial is testing

Genomic Profiling of Pancreatic Cystic Tumors

Who this might be right for
Pancreatic Cyst
Samsung Medical Center 250
Not applicableUnknownNCT05099068
What this trial is testing

Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)

Who this might be right for
Advanced / Metastic Solid TumorsGlioblastomaChronic Leukemia Lymphocytic
Centre Leon Berard 500
Not applicableUnknownNCT04692935
What this trial is testing

Comparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched Analysis

Who this might be right for
Adenocarcinoma of Lung
Jun Wang 450
Testing effectiveness (Phase 2)Study completedNCT02899793
What this trial is testing

Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer

Who this might be right for
Recurrent Endometrial Cancer
Yale University 25
Not applicableStudy completedNCT01954004
What this trial is testing

Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Myriad Genetic Laboratories, Inc. 1,270
Not applicableStudy completedNCT03739372
What this trial is testing

Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

Who this might be right for
GliomaGlioma of BrainCancer+5 more
University of California, San Francisco 44
Not applicableUnknownNCT03375437
What this trial is testing

RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.

Who this might be right for
Soft Tissue SarcomaAdvanced CancerMetastatic Cancer
Centre Leon Berard 376
Not applicableLooking for participantsNCT05906407
What this trial is testing

COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer

Who this might be right for
Early-Stage Breast CancerNeoadjuvant Therapy
German Cancer Research Center 2,000
Not applicableStudy completedNCT01919749
What this trial is testing

A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Translational Drug Development 25
Not applicableLooking for participantsNCT02215928
What this trial is testing

Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Stanford University 100
Not applicableActive Not RecruitingNCT05889195
What this trial is testing

Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria

Who this might be right for
Urothelial Carcinoma
Pacific Edge Limited 1,000
Not applicableUnknownNCT05542485
What this trial is testing

PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN Study

Who this might be right for
Non-small Cell Lung Cancer
Royal College of Surgeons, Ireland 97
Not applicableStudy completedNCT03491033
What this trial is testing

Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy

Who this might be right for
Advanced-stage Ovarian Cancer
Yonsei University 250
Next Page